Diksha Mohapatra

Dr. Diksha Mohapatra

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DMDiksha Mohapatra
Diksha Mohapatra
SPSwagatika Panda
Swagatika Panda
NMNeeta Mohanty
Neeta Mohanty
SPSourav Panda
Sourav Panda
NLNatalia Lewkowicz
Natalia Lewkowicz
BLBarbara Lapinska
Barbara Lapinska
The objective of the study was to compare the expression of immunohistochemical (IHC) markers of oral submucous fibrosis (OSMF) (non-transformed group) to those of oral squamous cell carcinoma (OSCC) transformed from OSMF (transformed group). The search for comparative cross-sectional studies was carried out in PubMed and Scopus abiding to the PICO criteria, where expression of IHC markers in OSMF were compared with that of OSCC transformed from OSMF. The cellular distribution, number of positive cases, staining intensity, and mean immunoreactive score (IRS) of each IHC marker were evaluated in both groups. A total of 14 studies were included in the systematic review, in which immunoexpression of 15 epithelial and 4 connective tissue biomarkers were evaluated. Expression of β1-integrin, OCT-3, CD1a, CD207, survivin, Dickkopf-1, COX-2, hTERT, CTGF, MDM2, Ki-67, and α-SMA were increased during transformation of OSMF to OSCC. Conversely, expression of PTEN and lysyl oxidase decreased during transformation of OSMF to OSCC. Expression of a group of epithelial markers, such as COX2, hTERT, CTGF, survivin, MDM2, and p53, was 38 times lower in the non-transformed group cases compared to transformed group cases (95% CI: 58% to 10%; p = 0.01; and I2 = 90%). Meta-analysis of all markers involved in cell metabolism/apoptosis, which included β1-integrin along with the above markers also suggested 42 times lower expression in the non-transformed group as compared to the transformed group (95% CI: 58% to 10%; p = 0.01; and I2 = 90%). Sub-group analyses on cytoplasmic and nuclear epithelial markers were inconclusive. Meta-analysis of connective tissue markers was also inconclusive. No publication bias was found. Instead of delving into numerous markers without a strong basis for their use, it is advisable to further study the markers identified in this study to explore their clinical utility.

Verified
Journal Article
Open access
PDF file
SCSayantanee Chaudhury
Sayantanee Chaudhury
SPSwagatika Panda
Swagatika Panda
NMNeeta Mohanty
Neeta Mohanty
SPSourav Panda
Sourav Panda
DMDiksha Mohapatra
Diksha Mohapatra
BLBarbara Lapinska
Barbara Lapinska
The objective was to evaluate the association of the immunoexpression of cancer stem cell (CSC) markers with clinicopathological and survival outcomes in tongue squamous cell carcinoma (TSCC) patients. This systematic review and meta-analysis [PROSPERO (CRD42021226791)] included observational studies that compared the association of clinicopathological and survival outcomes with CSC immunoexpression in TSCC patients. Pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CI) were used as outcome measures. Six studies identified the association with three surface markers (c-MET, STAT3, CD44) and four transcription markers (NANOG, OCT4, BMI, SOX2). The odds of early-stage presentation were 41% (OR = 0.59, 95% CI 0.42–0.83) and 75% (OR = 0.25; 95% CI 0.14–0.45) lower in CSC and SOX2 immuno-positive cases than immuno-negative cases, respectively. The odds of well-differentiated tumors in transcription marker immuno-positive cases were 45% lower compared to immuno-negative cases (OR = 0.55, 95% CI 0.32–0.96). The odds of positive lymph nodes were 2.01 times higher in CSC immuno-positive cases compared to immuno-negative cases (OR = 2.01, 95% CI 1.11–3.65). Mortality in immuno-positive cases was 121% higher than that in immuno-negative cases (HR = 2.21; 95% CI 1.16–4.21). Advanced tumor staging and grading, lymph node metastasis, and mortality were significantly associated with positive immunoexpression of CSC markers.

5 August 2025 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
PMPrabhudutta Mamidi
Prabhudutta Mamidi
SPSailendra Panda
Sailendra Panda
ARAmrita Ray
Amrita Ray
DMDiksha Mohapatra
Diksha Mohapatra
MMMadhab Charan Mandal
Madhab Charan Mandal
BMBaijayantimala Mishra
Baijayantimala Mishra

1 January 2019 in Indian Journal of Public Health Research & Development
Verified
Journal Article
Closed access
DMDiksha Mohapatra
Diksha Mohapatra
Oral submucous fibrosis is a chronic, insidious and highly potent precancerous condition of the oral cavity and sometimes affecting the pharynx.2 It is characterized by generalized inflammation and fibrosis of the submucosal tissues (lamina propria and deeper connective tissues).1 Oral Submucous fibrosis is a debilitating condition of the oral cavity with multifactorial etiology out of which areca nut chewing being the most common cause. There are various methodologies for management of this precancerous condition involving habit cessation, conservative treatment such as nutritional therapy and medical therapy, surgical interventions and oral physiotherapies, but, none of them has been able to provide permanent relief from the signs and symptoms. This review aims to focus various etiological factors behind the disease and treatment modalities available for treating this disease, mainly focusing upon the non-surgical approaches.

7 November 2025 in Cureus
Verified
Journal Article
Open access
PDF file
DMDiksha Mohapatra
Diksha Mohapatra
Background: Oral squamous cell carcinoma (OSCC) is one of the most common cancers of the oral cavity detected worldwide due to delayed clinical diagnosis, expensive therapeutic procedures, and poor prognosis. Oral submucous fibrosis (OSMF) is an oral potentially malignant disorder (OPMD) marked by abnormal collagen production which has a high malignant transformation rate. Subsequent changes occur in the epithelium and connective tissue simultaneously in a coordinated manner and can be aptly mentioned as epithelial-mesenchymal transition (EMT) that facilitates invasiveness and metastasis in carcinomas. The study was conducted to evaluate the immunohistochemical expression of cancer stem cell markers (CSM) OCT-4 and NANOG in OSMF (OSMF) patients, OSCC transformed from OSMF (OSCC+OSMF) patients, and OSCC not transformed from OSMF (OSCC-OSMF) patients. Additionally, the study sought to correlate the immunoexpression levels of OCT-4 and NANOG with the demographic and clinicopathological characteristics of OSMF, OSCC+OSMF, and OSCC-OSMF patients. Methodology: A total of 86 patients (30 OSMF, 30 OSCC+OSMF, and 26 OSCC-OSMF) were included in the study, wherein 86 haematoxylin and eosin-stained sections, 86 immunohistochemistry slides with OCT-4, and 86 immunohistochemistry slides with NANOG of the same patients were examined to analyse the role of OCT-4 and NANOG immunoexpression in the malignant transformation of OSMF. Result: A high proportion of OSMF (96.6%) and OSCC+OSMF (93.3%) samples showed positive OCT-4 expression, while only 42.3% of OSCC-OSMF cases were positive (p<0.001). NANOG showed a similar trend, being expressed in 93.3% of OSMF, 83.3% of OSCC+OSMF, and 38.5% of OSCC-OSMF samples (p<0.001). Both markers exhibited stronger staining intensity and higher immunoreactive scores in OSMF and OSCC+OSMF than in OSCC-OSMF. Odds ratio (OR) analysis indicated that OSCC+OSMF cases had significantly higher odds of OCT-4 (OR=5.23) and NANOG (OR=12.5) expression compared to OSCC-OSMF. Conclusion: The elevated expression of OCT-4 and NANOG in OSMF and OSCC+OSMF suggests their involvement in stem cell-driven pathways underlying malignant transformation. These markers may serve as valuable indicators for identifying OSMF patients at higher risk of developing OSCC and hold potential as prognostic and therapeutic indicators in oral carcinogenesis.

21 February 2026 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
DJDeepak Jena
Deepak Jena
PMPrabhudutta Mamidi
Prabhudutta Mamidi
SSSatya Ranjan Singh
Satya Ranjan Singh
MTManisha Tripathy
Manisha Tripathy
ARAmrita Ray
Amrita Ray
BMBaijayantimala Mishra
Baijayantimala Mishra